These references support the potential biomarkers or drug targets of the five anti-angiogenic proteins in PAD, such as CCL2 (Rull et al., 2011), NPPB (Hu et al., 2013), and SERPINE1 (Yasar et al., 2007). The gene discussed is CCL2; the disease is peripheral arterial disease.